Cell line · CVCL_1915
Papers35
50 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 35
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Comparative evaluation of oncolytic viruses reveals opposing preferences for glioblastoma subtypes. | Mol Ther Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gaps. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR. | Sci Prog | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The HDL-transporting scavenger receptor B1 promotes viral infection through endolysosomal acidification. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Characterization of the Temporal Dynamics of the Endothelial-Mesenchymal-like Transition Induced by Soluble Factors from Dengue Virus Infection in Microvascular Endothelial Cells. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade. | Mol Ther Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Mechanisms of active diffusion of vesicular stomatitis virus inclusion bodies and cellular early endosomes in the cytoplasm of mammalian cells. | PLoS One | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Sperm induction of somatic cell-cell fusion as a novel functional test. | Elife | 2024 | Its Methods give the RRID and name the line | PubMed | |
| mAb therapy controls CNS-resident lyssavirus infection via a CD4 T cell-dependent mechanism. | EMBO Mol Med | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. | Cell Host Microbe | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Mechanical transmission of dengue virus by Aedes aegypti may influence disease transmission dynamics during outbreaks. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Cellular resistance to an oncolytic virus is driven by chronic activation of innate immunity. | iScience | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity. | iScience | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication. | Mol Cell | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Lactate is an energy substrate for rodent cortical neurons and enhances their firing activity. | Elife | 2021 | Its Methods give the RRID and name the line | PubMed | |
| A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition. | Elife | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. | Cell Rep Med | 2021 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1915/papers